Pharmacoeconomic evaluation of jiuwei zhike oral liquid in the treatment of acute bronchitis with cough due to windheat syndrome
CHEN Yu
FANG Gang
PI Zhi-peng
LI Wei
DING Jin-xi
Abstract：Objective:To evaluate the cost-effectiveness of Jiuwei zhike oral liquid versus jizhi syrup in the treatment of acute bronchitis with cough due to windheat syndrome.Methods:The short-term cost-effectiveness analysis was conducted from the perspective of Chinese health system based on the phase Ⅲ clinical study of jiuwei xhike oral liquid.The health outcome was evaluated by cough disappearance time.The single factor and possibility sensitivity analysis were performed for key indicators.Furthermore,the disappearance rate of throat-drying symptom was used as the efficacy indicator in the scenario analysis to verify the robustness of the base case analysis.Results:The average cough disappearance time was shortened by 0.46 days while the cost was 26.41 Yuan higher.The incremental cost-effectiveness ratio value of jiuwei zhike oral liquid compared with jizhi syrup was 57.7 Yuan per day,which was less than China's daily per capita disposable income in 2023.Possibility sensitivity analysis showed that when the willingness to pay threshold was set up as 107.4 Yuan,jiuwei zhike oral liquid had a 93.8％chance of being more cost-effective compared to jizhi syrup.Results of scenario analysis was consistent with base case analysis results.Conclusion:jiuwei zhike oral liquid is cost-effective for acute bronchitis patients with cough due to windheat syndrome.
Keywords：jiuwei zhike oral liquidwind-heat syndromeacute bronchitiscost-effectiveness analysis
Publication Date：2025-11-30
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 2451-2455 )